Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Cochlear Limited    COH   AU000000COH5

COCHLEAR LIMITED

(COH)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
11/17/2020 11/18/2020 11/19/2020 11/20/2020 11/23/2020 Date
233.72 238.52 233.5 231.91 226.72 Last
277583 176683 222151 144675 198554 Volume
+0.33% +2.05% -2.10% -0.68% -2.24% Change
Financials
Sales 2021 1 475 M 1 080 M 1 080 M
Net income 2021 202 M 148 M 148 M
Net cash position 2021 265 M 194 M 194 M
P/E ratio 2021 70,5x
Yield 2021 0,48%
Sales 2022 1 709 M 1 251 M 1 251 M
Net income 2022 292 M 213 M 213 M
Net cash position 2022 320 M 234 M 234 M
P/E ratio 2022 49,7x
Yield 2022 1,40%
Capitalization 14 905 M 10 847 M 10 911 M
EV / Sales 2021 9,92x
EV / Sales 2022 8,54x
Nbr of Employees 4 000
Free-Float 99,4%
More Financials
Company
Cochlear Ltd is an Australia-based company that provides implantable hearing solutions. The Company provides bone conduction implants for people with conductive hearing loss, mixed hearing loss and single-sided deafness. Its segments include Americas, EMEA and Asia Pacific. Americas includes the United States, Canada and Latin America. EMEA includes Europe, Middle East and Africa. Asia Pacific includes Australasia... 
More about the company
Notations Surperformance© of Cochlear Limited
Trading Rating : Investor Rating :
More Ratings
All news about COCHLEAR LIMITED
11/11Xero's Net Profit Jumps as Customer Growth Continues in Pandemic -- Update
DJ
10/19Australia shares end at over 7-mth high as restrictions ease in Victoria
RE
08/13COCHLEAR LIMITED : annual earnings release
07/22Australia shares fall as record virus cases dent investor sentiment
RE
07/21Australia shares rise on stimulus, vaccine hopes
RE
04/16Australian companies race to raise capital, share placements top $6 billion
RE
03/26Asia bankers look to follow-on deals as capital raising hits 12-year low
RE
03/24COCHLEAR LIMITED : Ex-dividend day for interim dividend
FA
03/16COCHLEAR : Ord Minnett rates COH as Lighten
AQ
02/13COCHLEAR LIMITED : half-yearly earnings release
2019COCHLEAR LIMITED : Ex-dividend day for final dividend
FA
2019COCHLEAR LIMITED : Ex-dividend day for interim dividend
FA
2019COCHLEAR : advises of expansion to cochlear implant criteria in the UK
PU
2019COCHLEAR : Hearing loss affects relationships in millions of families worldwide
PU
2018COCHLEAR : announces next phase in development of totally implantable cochlear i..
PU
More news
News in other languages on COCHLEAR LIMITED
11/16Morning Briefing - Markt Schweiz
08/13COCHLEAR LIMITED : publication des résultats annuels
08/13COCHLEAR LIMITED : Veröffentlichung des Jahresergebnisses
05/19Sonova obtient gain de cause dans une affaire de brevets aux USA
02/13COCHLEAR LIMITED : publication des résultats semestriels
More news
Chart COCHLEAR LIMITED
Duration : Period :
Cochlear Limited Technical Analysis Chart | COH | AU000000COH5 | MarketScreener
Technical analysis trends COCHLEAR LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 196,37 AUD
Last Close Price 226,72 AUD
Spread / Highest target 6,30%
Spread / Average Target -13,4%
Spread / Lowest Target -39,1%
EPS Revisions
Managers
NameTitle
Diggory William Howitt President, CEO, Executive Director & MD
Roderick Holliday-Smith Chairman
Brent Andrew Cubis Chief Financial Officer
Jan Janssen Chief Technology Officer
David Hackshall Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COCHLEAR LIMITED0.89%10 847
ABBOTT LABORATORIES25.80%193 666
MEDTRONIC PLC-2.19%149 189
STRYKER CORPORATION10.99%87 507
BECTON, DICKINSON AND COMPANY-15.99%66 229
HOYA CORPORATION20.05%44 928